The chemical class of "ZNF717 Inhibitors" encompasses a diverse array of compounds that demonstrate the potential to indirectly modulate the activity of the protein encoded by the ZNF717 gene. This class highlights the intricate interplay between various biochemical pathways and the regulation of specific protein functions. By targeting cellular processes and signaling pathways interconnected with ZNF717's function, these inhibitors provide a nuanced approach to influencing protein activity beyond direct molecular interactions.
Among these compounds, agents like Bortezomib and Vorinostat represent the impact of targeting proteasome pathways and histone deacetylase activity, respectively. Bortezomib's role in impeding protein degradation pathways underscores the significance of protein turnover in the regulation of cellular functions, including those related to ZNF717. Vorinostat, through its influence on chromatin structure and gene expression, illustrates the profound effects of epigenetic modifications on protein activity.
DNA methyltransferase inhibitors such as 5-Azacytidine and Decitabine highlight the importance of epigenetic changes in gene expression, which can subsequently modulate the function of proteins like ZNF717. The inclusion of Rapamycin, a well-known mTOR inhibitor, underscores the role of cell growth and proliferation pathways in the overall modulation of protein activities within the cell.
The class also features immunomodulatory drugs like Lenalidomide and Thalidomide, showcasing how the modulation of immune signaling can indirectly impact the function of proteins involved in various cellular processes. In contrast, compounds like Disulfiram and Hydroxyurea demonstrate the influence of metabolic and DNA synthesis pathways on protein activity, providing insights into the complex network of cellular functions and their regulation.
The "ZNF717 Inhibitors" class not only underscores the multifaceted nature of biochemical interactions but also highlights the potential for indirect modulation of protein activities, leveraging the interconnected web of cellular pathways. This class offers a comprehensive understanding of protein regulation within the context of broader cellular and physiological processes. As research in this area advances, it is expected to reveal deeper insights into the regulation of proteins like ZNF717, enhancing our understanding of cellular mechanisms and opening new avenues for targeted intervention in disease processes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $256.00 | 18 | |
Tamoxifen, an estrogen receptor modulator, can influence hormonal signaling, potentially affecting ZNF717 activity. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Bortezomib, a proteasome inhibitor, can affect protein degradation pathways, potentially influencing ZNF717 activity. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Vorinostat, a histone deacetylase inhibitor, can affect chromatin structure and gene expression, potentially influencing ZNF717 activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin, an mTOR inhibitor, can modulate cell growth and proliferation, potentially influencing ZNF717 activity. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A, a histone deacetylase inhibitor, can influence gene expression, potentially affecting ZNF717 activity. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine, a DNA methyltransferase inhibitor, can affect DNA methylation, potentially influencing ZNF717 activity. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
Decitabine, a DNA methyltransferase inhibitor, can influence gene expression, potentially affecting ZNF717 activity. | ||||||
Lenalidomide | 191732-72-6 | sc-218656 sc-218656A sc-218656B | 10 mg 100 mg 1 g | $49.00 $367.00 $2030.00 | 18 | |
Lenalidomide, an immunomodulatory drug, can affect multiple signaling pathways, potentially influencing ZNF717 activity. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $109.00 $350.00 | 8 | |
Thalidomide, an immunomodulatory agent, can influence TNF-α production, potentially affecting ZNF717 activity. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $52.00 $87.00 | 7 | |
Disulfiram can affect aldehyde dehydrogenase, potentially influencing ZNF717 activity. | ||||||